Using flow cytometry, we investigated if diabetes alters the relative abundance of CD34+; SCA1+, and CD29High mesenchymal cells in the skin and determined if colocalization with profibrotic markers CD9 [47] and CD26 [22] was different in db/db skin compared to db/+ control skin (Figure S1A). The gene discussed is CD9; the disease is diabetes mellitus.